Lv1
70 积分 2022-03-22 加入
Minimal residual disease in solid tumors: an overview
13天前
已完结
Molecular residual disease: A new clue for individualized approach in non‐small cell lung cancer
15天前
已完结
Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification
1个月前
已完结
Oligometastasis: Past, Present, Future
2个月前
已完结
Oligometastases
2个月前
已完结
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
2个月前
已完结
The dormant cancer cell life cycle
2个月前
已完结
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
2个月前
已关闭
非小细胞肺癌T细胞受体(TCR)库在PD-1/PDL1抑制剂治疗中疗效预测作用及机制研究
8个月前
已完结
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
10个月前
已完结
皖公网安备34019202002308
